Clinical Trial Update: Characterization of the Pharmacodynamic Response to Vaped THC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial on the pharmacodynamic response to vaped THC was withdrawn after initiation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thc Exposure Effects
• Vaping-related Disorders

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Vaping, THC | Phase 3 | Status: WITHDRAWN